Abstract
Single-dose pegfilgrastim is commonly used for the prophylaxis of neutropenia in patients receiving myelotoxic chemotherapy. We report a case of a 69-year-old man who was treated with chemotherapy for small-cell lung cancer and mistakenly self-administered a 36 mg overdose of pegfilgrastim, a sixfold increase over the scheduled dose.
MeSH terms
-
Aged
-
Drug Overdose
-
Filgrastim
-
Granulocyte Colony-Stimulating Factor / administration & dosage
-
Granulocyte Colony-Stimulating Factor / adverse effects*
-
Humans
-
Male
-
Medication Errors / adverse effects*
-
Polyethylene Glycols
-
Recombinant Proteins / administration & dosage
-
Recombinant Proteins / adverse effects
-
Self Care / adverse effects*
-
Self Care / methods
Substances
-
Recombinant Proteins
-
Granulocyte Colony-Stimulating Factor
-
pegfilgrastim
-
Polyethylene Glycols
-
Filgrastim